Structures of DPAGT1 explain glycosylation disease mechanisms and advance TB antibiotic design
Yin Yao Dong,
Ashley CW Pike,
Stephen A. Cochrane,
Filip J. Wyszyński,
Simon R Bushell,
Sylvain F Royer,
David A. Widdick,
Helena I Boshoff,
Seung Seo Lee,
Shubhashish M.M. Mukhopadhyay,
Nicola A Burgess-Brown,
Mervyn J Bibb,
Clifton E Barry,
Carol V Robinson,
Benjamin G. Davis,
Elisabeth P Carpenter
Posted 02 Apr 2018
bioRxiv DOI: 10.1101/291278 (published DOI: 10.1016/j.cell.2018.10.037)
Posted 02 Apr 2018
Protein glycosylation is a widespread post-translational modification. The first committed step to the lipid-linked glycan used for this process is catalysed by dolichyl-phosphate N-acetylglucosamine-phosphotransferase DPAGT1 (GPT/E.C. 220.127.116.11). Missense DPAGT1 variants cause congenital myasthenic syndrome and congenital disorders of glycosylation. In addition, naturally-occurring bactericidal nucleoside analogues such as tunicamycin are toxic to eukaryotes due to DPAGT1 inhibition, preventing their clinical use as antibiotics. However, little is known about the mechanism or the effects of disease-associated mutations in this essential enzyme. Our structures of DPAGT1 with the substrate UDP-GlcNAc and tunicamycin reveal substrate binding modes, suggest a mechanism of catalysis, provide an understanding of how mutations modulate activity (and thus cause disease) and allow design of non-toxic lipid-altered tunicamycins. The structure-tuned activity of these analogues against several bacterial targets allowed design of potent antibiotics for Mycobacterium tuberculosis, enabling treatment in vitro, in cellulo and in vivo thereby providing a promising new class of antimicrobial drug.
- Downloaded 751 times
- Download rankings, all-time:
- Site-wide: 27,917
- In biochemistry: 655
- Year to date:
- Site-wide: 69,694
- Since beginning of last month:
- Site-wide: 43,606
Downloads over time
Distribution of downloads per paper, site-wide
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!